A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -15.36% this year. Over the last six months, there has been a stronger performance of -80.96%. The price of CATX leaped by -19.40% during the last 30 days period. For the last 5-days stocks have improved 3.45%.
Perspective Therapeutics Inc ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $19.05 on 05/15/24, while the lowest value for the same period was recorded at $2.32 on 03/04/25.
52-week price history of CATX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Perspective Therapeutics Inc’s current trading price is -85.83% away from its 52-week high, while its distance from the 52-week low is 16.38%. The stock’s price range during this period has varied between$2.32 and $19.05. The Perspective Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.53 million for the day, a figure considerably lower than their average daily volume of 1.0 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Perspective Therapeutics Inc (CATX) has experienced a quarterly decline of -34.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 182.49M and boasts a workforce of 119 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.69, with a change in price of -10.40. Similarly, Perspective Therapeutics Inc recorded 1,300,289 in trading volume during the last 100 days, posting a change of -79.39%.
CATX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CATX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
CATX Stock Stochastic Average
As of today, Perspective Therapeutics Inc’s raw stochastic average for the last 50 days stands at 19.79%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 31.15%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 16.54% and 12.59%, respectively.
